Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Günter Emons

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Cancer Research|July 30, 2009
GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein BaxStefanie Fister, Andreas R Günthert, Babette Aicher, et al.
Breast Cancer Research and Treatment|November 6, 2004
Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) systemAndreas R Günthert, Carsten Gründker, Till Bongertz, et al.
Prenatal Diagnosis|October 28, 2011
Cell-free fetal DNA in specimen from pregnant women is stable up to 5 daysSina P Müller, Iris Bartels, Werner Stein, et al.
European Journal of Endocrinology|July 14, 2004
Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptorCarsten Gründker, Lars Schlotawa, Volker Viereck, et al.
Cells|December 9, 2020
Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer CellsKatharina Kolb, Johanna Hellinger, Maike Kansy, et al.
American Journal of Obstetrics and Gynecology|September 19, 2002
Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude miceCarsten Gründker, Peter Völker, Frank Griesinger, et al.
American Journal of Obstetrics and Gynecology|October 28, 2004
Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) systemAndreas R Günthert, Carsten Gründker, Till Bongertz, et al.
Biochemical and Biophysical Research Communications|February 22, 2002
Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblastsVolker Viereck, Günter Emons, Vanessa Lauck, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 6, 2003
Analyzes of three common thrombophilic gene mutations in German women with recurrent abortionsHans-Ulrich Pauer, Thekla Voigt-Tschirschwitz, Bernd Hinney, et al.
Breast Cancer Research and Treatment|June 8, 2006
GnRH analogs reduce invasiveness of human breast cancer cellsJulia von Alten, Stefanie Fister, Hiltrud Schulz, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Cancer Research|July 30, 2009
GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein BaxStefanie Fister, Andreas R Günthert, Babette Aicher, et al.
Breast Cancer Research and Treatment|November 6, 2004
Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) systemAndreas R Günthert, Carsten Gründker, Till Bongertz, et al.
Prenatal Diagnosis|October 28, 2011
Cell-free fetal DNA in specimen from pregnant women is stable up to 5 daysSina P Müller, Iris Bartels, Werner Stein, et al.
European Journal of Endocrinology|July 14, 2004
Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptorCarsten Gründker, Lars Schlotawa, Volker Viereck, et al.
Cells|December 9, 2020
Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer CellsKatharina Kolb, Johanna Hellinger, Maike Kansy, et al.
American Journal of Obstetrics and Gynecology|September 19, 2002
Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude miceCarsten Gründker, Peter Völker, Frank Griesinger, et al.
American Journal of Obstetrics and Gynecology|October 28, 2004
Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) systemAndreas R Günthert, Carsten Gründker, Till Bongertz, et al.
Biochemical and Biophysical Research Communications|February 22, 2002
Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblastsVolker Viereck, Günter Emons, Vanessa Lauck, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 6, 2003
Analyzes of three common thrombophilic gene mutations in German women with recurrent abortionsHans-Ulrich Pauer, Thekla Voigt-Tschirschwitz, Bernd Hinney, et al.
Breast Cancer Research and Treatment|June 8, 2006
GnRH analogs reduce invasiveness of human breast cancer cellsJulia von Alten, Stefanie Fister, Hiltrud Schulz, et al.
Pageof 12